Biomarin Pharmaceutical (BMRN) Q4 2021 Earnings

27OctConfirmed
Q1 2021
Q2 2021
Q3 2021
Q4 2021
-0.25
-0.13
-0
0.12

Details

Expected EPS
-0.25
Actual EPS
-0.2
Surprise EPS
0.05
Surprise Percent
+20%

Description

Biomarin Pharmaceutical (BMRN) has reported earnings of -0.2 per share for Q4 2021.

0 Comments

Share your thoughts